Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 211 - 220 of 229 for CRO. (0.06 seconds)

Shanghai Institute of Materia Medica (SIMM) will form a...
BioPacific Investors, an US group of angel investors, has...
Crown Bioscience closed a $26.6 million...
Crown Bioscience, a preclinical US-China...
Crown Bioscience, a US-China preclinical...
Crown Bioscience, a US-China preclinical...
After going private two years ago, 3SBio of Shenyeng...
Green Cross, a South Korean biopharma,...
Porton Fine Chemicals of Chongqing will pay $42 million...
Green Cross of South Korea will build a...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital